Generic drug makers Arrow and Apotex have won the ACCC’s blessing for a tie-up that will create the largest generic drug supplier in Australia, with the competition regulator saying the deal will not substantially lessen competition.
Senator looks to shut down Hanson-Young defamation case
Union in UAE Exchange suit scolded for ‘throwing case into chaos’
Sirtex shareholders fear ‘bare cupboard’ for class action after takeover
Shareholders in a class action against Sirtex Medical have lost a bid for an order preventing the life sciences company from quietly moving $128 million in cash assets out of the country after its $1.9 billion takeover by a Chinese private equity company comes into effect Thursday, but the battle over the money will likely continue.